BIO is a curation and liquidity protocol focused on Decentralized Science (DeSci). Its primary goal is to enhance the biotechnology sector by empowering global communities, including patients, scientists, and biotech professionals, to collaboratively fund, develop, and possess tokenized biotech projects and intellectual property (IP). The creators of BIO have previously contributed to the development of Molecule, a tokenization platform aimed at early-stage biomedicine, and VitaDAO, the leading decentralized community in the longevity science field. Building on these achievements, BIO seeks to foster an on-chain scientific economy through innovative decentralized funding mechanisms, incentives, and increased liquidity. Holding the BIO token provides access to a network of scientific communities and intellectual property, allowing users to engage with and benefit from the growing DeSci economy. This structure not only facilitates investment but also promotes collaboration among stakeholders in the biotechnology landscape. Overall, BIO represents a significant step towards democratizing the funding and development of scientific advancements, creating a more inclusive environment for innovation in the biotechnology sector.